As part of the agreement, PDS Biotech received $25 million at the close and can receive an additional $10 million if needed. The loan will be paid back over 48 months, according to an Aug. 24 PDS Biotech news release provided to Becker’s.
Proceeds from the loan agreement will be used to support the clinical development of drug candidates.
Becker’s 3rd Annual Fall Chief Pharmacy Officer Summit is the top tier event that the people leading the future of pharmacy convene. This 3-day event is built specifically for Chief Pharmacy Officers and senior pharmacy leaders. The sessions examine the workforce, financial and clinical priorities shaping pharmacy today. Becker’s is where candid discussions flourish and new ideas thrive. Becker's 3rd Annual Fall Chief Pharmacy Officer Summit
